title: Advancing HIV prevention amidst an opioid epidemic in the United States.
authors.affiliation: Kevin Michael O'Hara is an assistant professor in the PA program at Yale School of Medicine in New Haven, Conn. The author has disclosed stock ownership in Gilead Sciences and Lipocine Inc.
authors.forename: Kevin Michael
authors.initials: KM
authors.lastname: OʼHara
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage; D058872:Epidemics; D015658:HIV Infections / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D016485:Needle Sharing / Q000009:adverse effects; D018671:Needle-Exchange Programs / Q000379:methods*; D009293:Opioid-Related Disorders / Q000150:complications / Q000453:epidemiology*; D065129:Pre-Exposure Prophylaxis / Q000379:methods*; D040242:Risk Reduction Behavior; D014481:United States / Q000453:epidemiology
chemical_list: D000998:Antiviral Agents